澳洲幸运5官方开奖结果体彩网

Micron Stock Falls but Analysts Are Bullish Despite Gross Margin 'Fly in the Ointment'

Micron Technology headquarters.

Bloomberg / Getty Images

Key Takeaways

  • Micron stock slid Friday following the company's fiscal second-quarter results.
  • Several analysts maintained bullish ratings, however, based in part on an improving outlook for its DRAM chips.
  • Investors may have reacted to Micron's gross margin projections, which one analyst called a "fly in the ointment."

Shares of Micron Technology (MU) turned lower Friday after 澳洲幸运5官方开奖结果体ꦚ彩网:the company’s fꦐiscal second-quarter results a day earlier🗹, but analysts have remained bullish on the memorꦯy chip company. 

Micron “has established technology leadership in [high-bandwith memory],” UBS analysts said after the results, and its DRAM chip business “should operate with more sustained supply/demand dynamics as long as AI continues to grow.” The bank maintained its “buy” rating and $130 price target. 

Despite 澳洲幸运5官方开奖结果体彩网:initially rising after the results were released, Micron shares dropped around 8% intraday Friday. The chipmaker’s revenue and profit forecast came in above Wall Street’s expectations, but UBS said the company’s commentary on 澳洲幸运5官方开奖结果体彩网:gross margins was “a bit of a fly in the ointment.” 

Citi analysts also reiterated a “buy” rating but trimmed their price target from $150 to $120 “given Micron’s persistent gross margin issues.” The bank raised its full-year sales and 澳洲幸运5官方开奖结果体彩网:earnings per share estimates, driven by expected improvements in the DRAM market. Meanwhile, Wedbush raised its price target to $130 from $125, and Bank of America stood pat at $110.

Do you have a news tip for Investopedia reporters? Please email us at
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.
  1. UBS. "Micron Technology Inc. NAND Still A Bit of A Drag, But The DRAM Story Is On Track."

  2. Citi. "Micron Technology Inc. Decent Results and Guide. DRAM Upturn Intact but Persistent Margin Softness Lowers Our Price Target. Reiterate Buy."

  3. BofA Securities. "Micron Technology, Inc. Elusive GM recovery constrains EPS power, Neutral."

  4. Wedbush. "Micron Technology Inc. HBM strength Moderates Weaker Commidity Conditions."

Compare Accounts
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.

Related Articles